- Home
- FG vs LGND Comparison
FG vs LGND Comparison
Compare FG & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FG | LGND |
|---|---|---|
| Founded | 1959 | 1987 |
| Country | United States | United States |
| Employees | N/A | 68 |
| Industry | Life Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.9B |
| IPO Year | N/A | 1992 |
Fundamental Metrics
Financial Performance| Metric | FG | LGND |
|---|---|---|
| Price | $33.73 | $184.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $41.00 | ★ $144.71 |
| AVG Volume (30 Days) | ★ 185.5K | 139.7K |
| Earning Date | 11-06-2025 | 08-05-2025 |
| Dividend Yield | ★ 2.97% | N/A |
| EPS Growth | ★ 3428.12 | N/A |
| EPS | ★ 3.42 | N/A |
| Revenue | ★ $5,559,000,000.00 | $181,488,000.00 |
| Revenue This Year | N/A | $18.41 |
| Revenue Next Year | $13.46 | $18.87 |
| P/E Ratio | $9.85 | ★ N/A |
| Revenue Growth | N/A | ★ 53.40 |
| 52 Week Low | $28.70 | $81.74 |
| 52 Week High | $47.82 | $129.90 |
Technical Indicators
Market Signals| Indicator | FG | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 65.94 | 38.34 |
| Support Level | $31.77 | $192.71 |
| Resistance Level | $32.68 | $201.49 |
| Average True Range (ATR) | 0.82 | 6.84 |
| MACD | 0.19 | -2.89 |
| Stochastic Oscillator | 98.31 | 3.79 |
Price Performance
Historical ComparisonAbout FG F&G Annuities & Life Inc.
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes (FABN) issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.